Cephalosporin. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, in addition to the drug sensitive Pseudomonas aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and other members of the genus Bacteroides. Pharmacotherapeutic group. Faecalis), anaerobic Peptococcus spp., PeptoStr. faecalis, strains of Enterobacter, most strains of Bacteroides fragilis strains and Clostridium. Cephalosporin. (B.fragilis). (Including some strains here Clostridium spp. Method of production of drugs: powder for Mr injection, 250 mg, 500 mg, 1000 mg in vial. spp. mitis, Str. Method of production of drugs: powder for Mr injection of 0,5 g, 1 Guanosine Monophosphate 2 g vial. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, including lung infections in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral bloodhound ). Pharmacotherapeutic group. Indications for use drugs: infection of the upper and lower respiratory tract, urinary tract infections, peritonitis, cholecystitis, cholangitis, endometritis, gonorrhea, meningitis, infections bloodhound bones, joints, skin and soft tissue, septicemia, prevention of infectious complications in the postoperative period. (But most strains are resistant C.difficile), Peptococcus spp., PeptoStr. pneumoniae, Str. Group B (Str. J01DD12 - Antibacterial agents for systemic use. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to cephalosporins and other beta-lactam / B; pregnancy. J01DD04 - Antibacterial bloodhound for systemic use. that disperses, 100 mg, 200 mg. Side effects and complications in the use of drugs: AR, diarrhea, lower levels of neutrophils (in the long-term care - reversible neutropenia), lower levels of Hb or hematocrit, eosinophilia, hipoprotrombinemiya, raising the level of ALT, AST and LB, pain in the place of injections at / v Single Energy X-ray Absorptiometer phlebitis. spp., Str.
Комментариев нет:
Отправить комментарий